Skip to main content
All lobbying filings

ARTEMIS POLICY GROUP LLC

Lobbying for SUSAN G. KOMEN · organization addressing breast cancer through research, community health, public policy

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · Texas · House · Senate · $40,000.00 income · posted Apr 21, 2025

Official filing document

 Bills named in this filing 5
  • S 864
    HELP Copays Act
  • HR 247
    Health Care Affordability Act of 2025
  • S 46
    Health Care Affordability Act of 2025
  • HR 842
    Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
  • HR 2381
    SCREENS for Cancer Act of 2025
 Lobbying activity 4
Budget/Appropriations

Appropriations for the National Breast and Cervical Cancer Early Detection Program Appropriations for breast cancer research Appropriations for cancer prevention and control Policies related to access to supplemental and diagnostic breast imaging

Insurance

Access to Breast Cancer Diagnosis (ABCD) Act; a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing. requirements with respect to diagnostic and supplemental breast examinations. Safe Step Act; a bill to require a group health plan to establish an exception to medication step-therapy protocol in specified cases. Implementation of the Affordable Care Act HELP Copays Act (/S.864); a bill to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. Cancer survivorship issues Issues related to prescription drug affordability for patients Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Congressional action to reduce out-of-pocket costs for medically necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Policies related to copay accumulator and maximizer adjustors Policies related to the extension of enhanced advanced premium tax credits Healthcare Affordability Act of 2024 (H.R. 247 / S. 46) a bill to expand eligibility for the refundable credit for coverage under a qualified health plan. Protect patients from substandard and junk insurance products

Medicare/Medicaid

Medicare coverage policy for breast cancer treatments and services Policies related to funding, state incentives, and federal efforts for Medicaid expansion Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to Medicare coverage for pharmacy services Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly proposed rule outlining revisions to Medicare Advantage (MA) and Medicare Part D for Contract Year 2026. Medicare Multi-Cancer Early Detection Screening Coverage Act (HR 842/S 339); a bill to provide for Medicare coverage of multi-cancer early detection screening tests.

Health Issues

Access to clinical trials for underrepresented populations Policies related to cancer survivorship Policies related to medications access during emergencies Polices related to PBM and drug cost transparency Policies related to reducing the cost of cancer treatment for patients Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381) Policies related to administrative actions necessary in breast imaging and breast cancer diagnosis Policies related to the regulation of diagnostic devices, Comments in response to proposed updates to HRSA-Supported Womens Preventive Services Guidelines Policies to remove the notice and comment process for a wide array of agency actions Policies related to rapid and large-scale reductions-in-force (RIFs) and reorganizations of departments

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem